Trial intelligence / Profile preview

Impact of exercise training and insulin treatment in patients with type 2 diabetes treated with metformin

2006-003269-15Phase 4Terminated

Sponsor
Karolinska University Hospital
Start
Jul 2006
Modality
Small Molecules, Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4, randomised trial of insulin aspart and metformin in type 2 diabetes mellitus (T2DM) (3 arms), sponsored by Karolinska University Hospital. Primary endpoint: Glycemic control (HbA1c after 20 weeks). Started Jul 2006; status: terminated.

02

Drugs

insulin aspartmetformin
03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on 2006-003269-15.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-003269-15.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call